FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to a new glycopeptide antibiotic derivative of formula 
(IV-1), a method for preparing it, and to intermediate compounds for preparing it.
EFFECT: glycopeptide derivative has antibacterial activity on a vancomycin-resistant bacterium.
14 cl, 51 tbl, 121 ex
| Title | Year | Author | Number |
|---|---|---|---|
| HETEROCYCLIC DERIVATIVE HAVING ACTIVATING AMPK ACTIVITY | 2015 |
|
RU2700703C2 |
| MACROCYCLIC SERINE PROTEASE INHIBITORS | 2009 |
|
RU2490272C2 |
| TRIAZINE DERIVATIVE AND PHARMACEUTICAL COMPOSITION INCLUDING IT, POSSESSING ANALGESIC ACTIVITY | 2011 |
|
RU2565073C2 |
| MDM2 AND P53 INTERACTION INHIBITORS | 2008 |
|
RU2477724C2 |
| ANTIVIRAL ACTIVE COMPONENT, PHARMACEUTICAL COMPOSITION, MEDICINAL AGENT, METHOD OF TREATING VIRAL DISEASES | 2009 |
|
RU2407738C1 |
| SIP RECEPTOR MODULATORS FOR TREATING MULTIPLE SCLEROSIS | 2007 |
|
RU2495664C2 |
| S1P RECEPTOR MODULATORS FOR MULTIPLE SCLEROSIS TREATMENT | 2007 |
|
RU2617502C2 |
| MONOMER DERIVATIVES OF GLYCOPEPTIDE ANTIBIOTIC | 2005 |
|
RU2424248C2 |
| DERIVATIVES OF 2-OXY-4H-3,1-BENZOXAZINE-2-ONE FOR PROPHYLAXIS AND/OR TREATMENT OF OBESITY OR ACCOMPANYING DISORDER | 2000 |
|
RU2245331C2 |
| IMIDZOL DERIVATIVE CONDENSED HETEROCYCLE HAVING ACTIVE AMPK EFFECT | 2011 |
|
RU2635662C2 |
